Academic Journal
Q2Journal of Alzheimer’s Disease Reports
About Journal of Alzheimer’s Disease Reports
Journal of Alzheimer's Disease Reports is a scholarly journal published by SAGE Publications Ltd. SCImago 2025 lists it in Q2, with an SJR of 0.885 and H-index of 32.
Coverage: 2017-2025. Research categories: Clinical Psychology (Q2); Geriatrics and Gerontology (Q2); Neuroscience (miscellaneous) (Q2); Psychiatry and Mental Health (Q2).
Open-access policies and author information
Reported in the official DOAJ public CSV snapshot (2026-09-01), downloaded 2026-10-03. Record updated 2025-06-10. This snapshot does not establish today’s listing status or fee quotation.
Publisher policy links recorded by DOAJ
- Aims and scope ↗
- Editorial board ↗
- Instructions for authors ↗
- Peer-review policy ↗
- Publication fees ↗
- Fee waivers ↗
- Licence terms ↗
- Copyright policy ↗
- Preservation policy ↗
Source: DOAJ journal record. Journal metadata is distributed by DOAJ under CC0. Confirm current fees, tax, eligibility and waiver terms with the publisher.
Source-backed journal facts
Topics in published research
Dementia and Cognitive Impairment Research; Alzheimer's disease research and treatments; Neuroinflammation and Neurodegeneration Mechanisms; Neurological Disease Mechanisms and Treatments; Functional Brain Connectivity Studies; Cholinesterase and Neurodegenerative Diseases.
OpenAlex classifies topics from published works. These topics are not the publisher’s official aims and scope.
Source: OpenAlex source record. Retrieved 2026-10-03. Source record updated 2026-10-02. OpenAlex metrics are different from SCImago metrics and the Clarivate Journal Impact Factor.
Journal Metrics
Quartile, SJR and the listed SCImago H-index use the 2025 imported SCImago dataset. A quartile may vary by subject category. Values without a source or reporting year are unverified historical entries. Verify the current Journal Impact Factor with Clarivate or the publisher before using it.
Aims & Scope
The publisher’s official aims and scope have not yet been verified for this profile. Use the journal website to check subject fit and accepted article types before submitting.
Recent Research Articles
Latest publications matched automatically by ISSN.
Prognostic value of baseline plasma p-tau217 for incident cognitive impairment in cognitively unimpaired cohorts: A systematic review and meta-analysis
Aasim Ali, Sara Jamil, Aswad Mustafa, Zainab Nabeel et al.
2026-09 · DOI: 10.1177/25424823261487920Uptake and safety profile of anti-amyloid immunotherapies in routine clinical practice
Jay B. Lusk, Kate Vinita Fitch, Kim G. Johnson, Andy Liu et al.
2026-09 · DOI: 10.1177/25424823261483526Antioxidant intake relative to established dietary recommendations and cognitive status in older adults
Kelly Knoll, Halli Heimbuch, Ryan McGrath, Megan Orr et al.
2026-09 · DOI: 10.1177/25424823261487699Caregiver burden, not patient cognitive impairment, predicts adherence to donepezil transdermal patch in Alzheimer's disease: A retrospective real-world study
Ryuji Yajima, Takanobu Ishiguro, Makoto Michikawa, Satoshi Naruse et al.
2026-09 · DOI: 10.1177/25424823261468306Nipah virus infection as a putative risk factor for Alzheimer's disease: A testable hypothesis
Navakanth Raju Ramayanam, Sarad Pawar Naik Bukke, Badvel Jeevan Kumar, Nithin Vidiyala et al.
2026-09 · DOI: 10.1177/25424823261490069Dissecting the sex-dependent muscle–brain axis: Hippocampal subfields mediate the association between grip strength and cognition in amnestic mild cognitive impairment
Wen-Juan Song, Guo-Hui Zhang, Pu Zhao, Jia-Jia Wu et al.
2026-09 · DOI: 10.1177/25424823261493009Artificial intelligence algorithms for the prediction of cognitive decline and dementia: A theoretical–historical narrative review
Rubén Sanz-Blasco, Miguel Ángel Fernández-Blázquez, Emilio Verche, José Antonio Muñiz-Casado et al.
2026-09 · DOI: 10.1177/25424823261472106The trajectory of delusions in patients with Alzheimer's disease receiving pharmacological treatment: A re-analysis of data from the CATIE-AD trial
Katsuharu Yano, Tomoyuki Nagata, Shinichiro Nakajima, Shinsuke Kito et al.
2026-09 · DOI: 10.1177/25424823261494480Brain health in older adults: At the crossroads of frailty and resilience
Mohammad Shahadat Hossain, Domenico Praticò
2026-09 · DOI: 10.1177/25424823261493062Association between occlusal support, salivary amyloid-β42 levels, and cognitive function in older adults: A cross-sectional pilot study
Mariska Juanita, Bahruddin Talib, Acing Habibie Mude, Yukinori Maruo et al.
2026-09 · DOI: 10.1177/25424823261478548Safety, acceptability, and usability of an immersive gamification technology system for use in patients with behavioral and psychological symptoms of dementia (phase 1 trial)
Veeda Michelle M. Anlacan, Roland Dominic G. Jamora, Angelo Cedric F. Panganiban, Bryan Andrei C. Galecio et al.
2026-09 · DOI: 10.1177/25424823261476614A study on comprehensive bibliometric analysis of natural medicines for Alzheimer's disease (1999–2025)
Yue Chen, Huihuang Shi, Sicheng Chen, Zhu Li et al.
2026-09 · DOI: 10.1177/25424823261478276Symptomatic lobar intracerebral hemorrhage during extended lecanemab treatment: A case report
Yugo Takahashi, Naoyuki Shiraishi, Akihiro Tsukahara, Yukari Matsuda et al.
2026-09 · DOI: 10.1177/25424823261487915Steroid-responsive inflammatory leptomeningeal encephalitis temporally associated with lecanemab therapy: A case report
Yuichiro Tagane, Masahiro Nakamori, Marina Ishida, Saya Tsuchigauchi et al.
2026-09 · DOI: 10.1177/25424823261483284Critical review of the foundational studies on chronic traumatic encephalopathy in American football players
Ira R. Casson, David C. Viano
2026-09 · DOI: 10.1177/25424823261489698Exploratory epilepsy-derived transcriptomic projection reveals region-sensitive molecular remodeling in Alzheimer's disease
Nannan Pan, Penghui Cao, Cuiling Zhang, Fengchun Wu et al.
2026-08 · DOI: 10.1177/25424823261483598Association between different types of tea consumption frequency and sleep quality with cognitive function among older adults in Qingdao rural area
Ling Zhang, Wenqi Zhao, Zhenxue Song, Jingyi Zhang et al.
2026-08 · DOI: 10.1177/25424823261479949Brain single-cell transcriptome-informed Mendelian randomization identifies potential druggable therapeutic targets for Alzheimer's disease
Renjun Huang, Liqing Guan, Yang Chen, Qiang Jiao et al.
2026-08 · DOI: 10.1177/25424823261478529Blood lipids as accessible biomarkers for early dementia risk screening: Bridging diagnostic gaps in resource-limited settings
Foster Appiah, David Larbi Simpong, George Nkrumah Osei, John Dogah et al.
2026-08 · DOI: 10.1177/25424823261475263Association of HIV infection with dementia and cognitive impairment: A systematic review and meta-analysis
Shuolong Li, Xinyue Yin, Daiyu Song, Guoyong Ding et al.
2026-08 · DOI: 10.1177/25424823261478284Reviews
Community Reviews
Version History
October 2, 2026 at 8:32 pm
October 2, 2026